Literature DB >> 15270209

Parameters affecting the results in a program of artificial insemination with donor sperm. A 12-year retrospective review of more than 1800 cycles.

J L Zuzuarregui1, M Meseguer, N Garrido, C Simón, A Pellicer, J Remohí.   

Abstract

PURPOSE: We aimed to establish the influence of the parameters affecting artificial insemination (AI) results in order to describe the ideal situations to achieve the best results as well as to adequately counsel the patients undergoing these treatments about their pregnancy chances.
METHODS: We performed a controlled retrospective clinical study over more than one decade in a total of 1858 cycles in 710 patients. Clinical histories and computer registers were systematically reviewed between January 1990 and June 2002. We analyzed the influence of diverse factors affecting AI results such as patient's age, ovarian stimulation, and seminal characteristics to offer a detailed description of the technique.
RESULTS: Less than 35-years-old, smooth ovarian stimulation and 5 million of progressive motile sperm inseminated two consecutive days are the optimum conditions for achieving good results. Also, period of time that sperm remained frozen do not affect the result. Furthermore, we present the likely or expected outcomes of these treatments depending on the male and female etiologies.
CONCLUSIONS: We discourage AI in aged patients, and strongly recommend undergoing ovarian stimulation. Nonetheless, we must reach an adequate amount of sperm with good motility in order to inseminate with maximum guaranties of success.

Entities:  

Mesh:

Year:  2004        PMID: 15270209      PMCID: PMC3455611          DOI: 10.1023/b:jarg.0000029494.55273.a2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  10 in total

1.  Sperm and oocyte donor selection and management: experience of a 10 year follow-up of more than 2100 candidates.

Authors:  N Garrido; J L Zuzuarregui; M Meseguer; C Simón; J Remohí; A Pellicer
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

2.  Comparison of polymerase chain reaction-dependent methods for determining the presence of human immunodeficiency virus and hepatitis C virus in washed sperm.

Authors:  Marcos Meseguer; Nicolás Garrido; Concha Gimeno; José Remohí; Carlos Simón; Antonio Pellicer
Journal:  Fertil Steril       Date:  2002-12       Impact factor: 7.329

Review 3.  Intrauterine insemination: a first-step procedure in the algorithm of male subfertility treatment.

Authors:  W Ombelet; P Puttemans; E Bosmans
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

4.  Predictors of success with the use of donor sperm.

Authors:  R S Williams; J Alderman
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

5.  Results of 6139 artificial insemination cycles with donor spermatozoa.

Authors:  A Botchan; R Hauser; R Gamzu; L Yogev; G Paz; H Yavetz
Journal:  Hum Reprod       Date:  2001-11       Impact factor: 6.918

6.  Two-day IUI treatment cycles are more successful than one-day IUI cycles when using frozen-thawed donor sperm.

Authors:  M Matilsky; Y Geslevich; M Ben-Ami; I Ben-Shlomo; T Weiner-Megnagi; E Shalev
Journal:  J Androl       Date:  1998 Sep-Oct

7.  Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime.

Authors:  I Ferrara; R Balet; J G Grudzinskas
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

8.  Female fertility and donor insemination.

Authors:  J C Emperaire; E Gauzere-Soumireu; A J Audebert
Journal:  Fertil Steril       Date:  1982-01       Impact factor: 7.329

9.  Methods to increase the success rate of artificial insemination with donor semen.

Authors:  H T Depypere; S Gordts; R Campo; F Comhaire
Journal:  Hum Reprod       Date:  1994-04       Impact factor: 6.918

10.  The outcome of artificial donor insemination compared to the husband's fertility status.

Authors:  G T Kovacs; J F Leeton; C D Matthews; S J Steigrad; D M Saunders; W R Jones; R Lyneham; R McMaster
Journal:  Clin Reprod Fertil       Date:  1982-12
  10 in total
  6 in total

1.  Ovarian stimulation length, number of follicles higher than 17 mm and estradiol on the day of human chorionic gonadotropin administration are risk factors for multiple pregnancy in intrauterine insemination.

Authors:  Nicolás Garrido; Marco A B Melo; Carlos Simón; José Remohí; Antonio Pellicer; Marcos Meseguer
Journal:  Reprod Med Biol       Date:  2007-02-16

2.  Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy.

Authors:  Moses Tar; Pedro Cabrales; Mahantesh Navati; Brandon Adler; Parimala Nacharaju; Adam J Friedman; Joel Friedman; Kelvin P Davies
Journal:  J Sex Med       Date:  2014-10-09       Impact factor: 3.802

3.  Intrauterine insemination with donor sperm: only the number of motile spermatozoa inseminated influences both pregnancy and live-birth rates.

Authors:  Marie Cardey-Lefort; Berengere Ducrocq; Audrey Uk; Helen Behal; Anne-Laure Barbotin; Geoffroy Robin
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

4.  Pregnancy and offspring outcomes after artificial insemination with donor sperm: A retrospective analysis of 1805 treatment cycles performed in Northwest China.

Authors:  Aiping Zhang; Xiaoling Ma; Lili Zhang; Xuehong Zhang; Weihua Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Clinical variables affecting the pregnancy rate of intracervical insemination using cryopreserved donor spermatozoa: a retrospective study in china.

Authors:  Xiao-Jun Chen; Li-Ping Wu; Hai-Lian Lan; Li Zhang; Yi-Min Zhu
Journal:  Int J Fertil Steril       Date:  2012-12-17

6.  Factors Affecting Artificial Insemination Pregnancy Outcome.

Authors:  Xue Wang; Yue Zhang; Hong-Liang Sun; Li-Ting Wang; Xue-Feng Li; Fei Wang; Yan-Lin Wang; Qing-Chun Li
Journal:  Int J Gen Med       Date:  2021-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.